Importantly, numerous studies have also indicated a downregulation of CB1R and/or CB2R in a few human cancer types, including glioma [79], colorectal cancer [107,108], endometrial [95], hepatocellular [100], and renal cell carcinomas [109]. Here, CNR1 is linked to glioma.